Study - Enrolling
Pediatric Atopic Dermatitis Clinical Trials
Watching your baby scratch is hard on every parent. Enroll in Pediatric Atopic Dermatitis Clinical Trials and see if your little one qualifies today.
About this study
Pediatric atopic dermatitis clinical trials like this one study an investigational cream in children between 3 and 23 months old in Colorado. Researchers want to learn how safe and effective the cream is for very young skin. Their findings could also help shape future care for the youngest children living with atopic dermatitis.
Who may be able to take part?
Children between 3 and 23 months old with atopic dermatitis may be eligible for pediatric atopic dermatitis clinical trials like this eczema research study in Colorado. The Physician Research Group (PRG) study team screens each child to confirm the requirements are met, and parents or caregivers share updates about their child’s skin condition and any changes.
What participation may involve?
Pediatric atopic dermatitis clinical trials begin with a screening visit. Eligible children then receive study care according to the protocol. At scheduled visits, researchers check safety, response to the study cream, and overall health. Taking part may bring an atopic dermatitis treatment option closer to the youngest children.
Thinking about eczema clinical trials for your child? Bring these questions along to your visit with the team:
How often will my child need to come in for visits?
What side effects should I watch for, and who do I call if I have a concern?
What happens at visits in this atopic dermatitis research study in Colorado?
Questions to ask the study team
Study at a glance
Study Status
Recruiting
Age
3 Months to 23 Months
Location
Colorado
We're Here to Help!
Thinking about joining a research study but not sure where to start? We're happy to answer your questions, walk you through the process, and help you explore whether a study is right for you.
Frequently Asked Questions
-
This pediatric atopic dermatitis clinical trial is designed to evaluate the safety and effectiveness of an investigational cream in children between 3 months and 23 months of age with atopic dermatitis. The study helps researchers better understand how the investigational treatment performs in young children.
-
Children between 3 months and 23 months of age who have atopic dermatitis may be eligible to participate. A screening process will be conducted by the study team to determine if a child meets the requirements for enrollment.
-
During the study, participants will attend scheduled visits where researchers will monitor safety, evaluate treatment response, and assess overall health. Parents or caregivers will provide updates about their child’s condition and any changes observed throughout the trial.